NCT05984173

Brief Summary

90 female patients seeking extraction of a single tooth in the lower posterior region were divided randomly into 45 patients received vitamin E inside the socket after extraction (study group) and 45 patients didn't receive vitamin E after extraction (control group).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2022

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 9, 2023

Completed
Last Updated

August 9, 2023

Status Verified

January 1, 2023

Enrollment Period

11 months

First QC Date

July 22, 2023

Last Update Submit

August 8, 2023

Conditions

Keywords

dry socket

Outcome Measures

Primary Outcomes (1)

  • Decrease of incidence of dry socket and pain

    Evaluation of patient satisfaction and pain was done and recorded according to VAS which is a scale from 1-10. patient mention degree of pain on this scale

    one week

Study Arms (2)

study group

EXPERIMENTAL

patients received vitamin E inside the socket after extraction (study group)

Drug: Vitamin E application

control

NO INTERVENTION

patients didn't receive vitamin E after extraction (control group).

Interventions

patients received vitamin E inside the socket after extraction

Also known as: tocopherol
study group

Eligibility Criteria

Age30 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsonly biological female because estrogen is limiting factor
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female patients 30-50 years of age.
  • Patients with single tooth in the lower posterior region need simple extraction.
  • Compliance with all requirements in the study and signing the informed consent.

You may not qualify if:

  • Patients with any medical condition that may influence the outcome (uncontrolled diabetes, Hyperparathyroidism, Hyperthyroidism, Cushing's disease, Paget's disease, Glucocorticoids).
  • Vulnerable groups (children, pregnant women, elderly people, malnourished people, prisoners, migrants, and refugees).
  • Patients with systemic disease affecting bone healing (osteoporosis, Rickets, and osteomalacia).
  • Chronic Patients on medications known to affect the periodontal status (calcium antagonists, anticonvulsive, immunosuppressive, anti-inflammatory medications).
  • Patients with a history of bisphosphonate use.
  • Pathologic lesions in the site of extraction.
  • Lactating mothers.
  • Smoking patients.
  • Patients currently on radiotherapy and or chemotherapy treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain shams University

Cairo, 11757, Egypt

Location

Related Publications (1)

  • Blum IR. Contemporary views on dry socket (alveolar osteitis): a clinical appraisal of standardization, aetiopathogenesis and management: a critical review. Int J Oral Maxillofac Surg. 2002 Jun;31(3):309-17. doi: 10.1054/ijom.2002.0263.

MeSH Terms

Conditions

Dry Socket

Interventions

Tocopherols

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Vitamin EBenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • mohamed diaa

    Ain shams

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Double blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical trial two groups
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2023

First Posted

August 9, 2023

Study Start

January 1, 2022

Primary Completion

December 1, 2022

Study Completion

December 10, 2022

Last Updated

August 9, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Not planning to share

Locations